RECENT POSTS

18

Jul, 2014

Clinical Trials – Multi Site

By: | Tags: , , | Comments: 0

BioMark is proud to partner and cooperate with National Cancer Institute in Bangladesh and BioMark China in a phase III multi site trial. The trail will involve over 400 subjects and will focus on 4 cancer indications. All the procedures will follow North American regulatory guidelines that were prepared by Saint Boniface Research centre’s regulatory group.

READ MORE

18

Jul, 2014

Commercialization and Prototype Development

By: | Tags: , , | Comments: 0

Elisa Kit Development – BioMark has successfully developed Elisa kits using antibodies generated at UBC’s Biomedical Research Centre by Dr. Schrader and his team. The kits were developed under CLSI specifications and are under key customer test site. Double blinded study was also designed to ensure the reliability of the test kits Point Of Care System – Next generation IVD point of care system is being developed in Canada after…

READ MORE